Throughout 2011 and 2012, a wave of generic versions for several top-selling drugs will roll out as brand-name prescriptions go off patent.
According to the Associated Press, the magnitude of this wave of expiring drugs patents is unprecedented. [See Drug prices to plummet]
Sales for these drugs is more than $250 billion annually, and it's expected that generic competition will "decimate sales of the brand-name drugs and slash the cost to patients and companies that provide health benefits."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
